Smart for Life (SMFL) Competitors $0.0036 +0.00 (+38.46%) As of 09:37 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock SMFL vs. HEPA, NAVB, SCPS, EVLO, CMRA, GNCAQ, GNCA, ARDS, STAB, and PXMDShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Hepion Pharmaceuticals (HEPA), Navidea Biopharmaceuticals (NAVB), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Comera Life Sciences (CMRA), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), and PaxMedica (PXMD). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Hepion Pharmaceuticals Navidea Biopharmaceuticals Scopus BioPharma Evelo Biosciences Comera Life Sciences Genocea Biosciences Genocea Biosciences Aridis Pharmaceuticals Statera Biopharma PaxMedica Hepion Pharmaceuticals (NASDAQ:HEPA) and Smart for Life (NASDAQ:SMFL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability. Which has higher earnings & valuation, HEPA or SMFL? Smart for Life has higher revenue and earnings than Hepion Pharmaceuticals. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHepion PharmaceuticalsN/AN/A-$48.93M-$219.000.00Smart for Life$11.11M0.00-$22.68MN/AN/A Does the MarketBeat Community favor HEPA or SMFL? Hepion Pharmaceuticals received 20 more outperform votes than Smart for Life when rated by MarketBeat users. However, 100.00% of users gave Smart for Life an outperform vote while only 67.74% of users gave Hepion Pharmaceuticals an outperform vote. CompanyUnderperformOutperformHepion PharmaceuticalsOutperform Votes2167.74% Underperform Votes1032.26% Smart for LifeOutperform Votes1100.00% Underperform VotesNo Votes Do insiders & institutionals believe in HEPA or SMFL? 17.2% of Hepion Pharmaceuticals shares are owned by institutional investors. Comparatively, 28.4% of Smart for Life shares are owned by institutional investors. 4.7% of Hepion Pharmaceuticals shares are owned by insiders. Comparatively, 31.7% of Smart for Life shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more risk and volatility, HEPA or SMFL? Hepion Pharmaceuticals has a beta of 1.79, indicating that its stock price is 79% more volatile than the S&P 500. Comparatively, Smart for Life has a beta of 1.42, indicating that its stock price is 42% more volatile than the S&P 500. Does the media favor HEPA or SMFL? In the previous week, Hepion Pharmaceuticals had 1 more articles in the media than Smart for Life. MarketBeat recorded 1 mentions for Hepion Pharmaceuticals and 0 mentions for Smart for Life. Hepion Pharmaceuticals' average media sentiment score of 0.00 equaled Smart for Life'saverage media sentiment score. Company Overall Sentiment Hepion Pharmaceuticals Neutral Smart for Life Neutral Is HEPA or SMFL more profitable? Smart for Life's return on equity of 0.00% beat Hepion Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Hepion PharmaceuticalsN/A -812.56% -207.31% Smart for Life N/A N/A N/A SummarySmart for Life beats Hepion Pharmaceuticals on 7 of the 10 factors compared between the two stocks. Remove Ads Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$26,000.00$1.16B$5.24B$7.07BDividend YieldN/AN/A4.87%4.05%P/E RatioN/A9.2821.2017.46Price / Sales0.005.77356.3585.24Price / CashN/A10.4038.1634.64Price / Book0.001.106.233.79Net Income-$22.68M-$56.07M$3.20B$247.10M7 Day PerformanceN/A-10.12%-8.32%-7.32%1 Month PerformanceN/A-16.14%-3.36%-10.20%1 Year PerformanceN/A-48.67%2.72%-7.41% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.00+38.5%N/A-99.9%$26,000.00$11.11M0.00110Gap DownHEPAHepion Pharmaceuticals0.3345 of 5 stars$0.49+12.8%N/A-99.6%$67,000.00N/A-0.1120Gap UpHigh Trading VolumeNAVBNavidea BiopharmaceuticalsN/A$0.00flatN/A-98.6%$40,000.00$8,126.000.0010SCPSScopus BioPharmaN/A$0.00flatN/A-50.0%$13,000.00N/A0.009EVLOEvelo BiosciencesN/A$0.00flatN/A-99.0%$9,000.00N/A0.00120Options VolumeNews CoverageCMRAComera Life SciencesN/A$0.00flatN/AN/A$6,000.00$1.00M0.002GNCAQGenocea BiosciencesN/AN/AN/AN/A$6,000.00N/A0.0070GNCAGenocea BiosciencesN/AN/AN/AN/A$6,000.00$1.91M0.0070Analyst ForecastNews CoverageARDSAridis PharmaceuticalsN/A$0.00flatN/AN/A$5,000.00$3.09M0.0030STABStatera BiopharmaN/A$0.00flatN/A-83.3%$5,000.00N/A0.0020PXMDPaxMedicaN/A$0.00flatN/AN/A$2,000.00N/A0.002 Remove Ads Related Companies and Tools Related Companies Hepion Pharmaceuticals Competitors Navidea Biopharmaceuticals Competitors Scopus BioPharma Competitors Evelo Biosciences Competitors Comera Life Sciences Competitors Genocea Biosciences Competitors Genocea Biosciences Competitors Aridis Pharmaceuticals Competitors Statera Biopharma Competitors PaxMedica Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SMFL) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SMFL Stock Free SMFL Stock Alerts